This topic contains a solution. Click here to go to the answer

Author Question: Deliberately inducing discomfort or anxiety in an interviewee a. should always be avoided. b. is ... (Read 169 times)

Zulu123

  • Hero Member
  • *****
  • Posts: 525
Deliberately inducing discomfort or anxiety in an interviewee
 
  a. should always be avoided.
  b. is likely to increase how much information an interviewee reveals.
  c. is related to the interviewer's training.
  d. is appropriate for certain types of interviews.

Question 2

What system is standardized to have a mean of 5 and a standard deviation of approximately 2?
 
  a. Decile
 b. McCall's T
  c. Stanine
 d. Quartile



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jsm54321

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

d

Answer to Question 2

c




Zulu123

  • Member
  • Posts: 525
Reply 2 on: Jun 19, 2018
:D TYSM


lindahyatt42

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

As the western states of America were settled, pioneers often had to drink rancid water from ponds and other sources. This often resulted in chronic diarrhea, causing many cases of dehydration and death that could have been avoided if clean water had been available.

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library